In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

The Pharma Skills-Based Economy Emerges

The Great Resignation Has Catalyzed The Drive To Ditch The University Degree In Favor Of Skills And Values

Executive Summary

Resetting requirements for jobs, with the importance of degrees and higher education lessened in favor of appropriate skills and talent, is a trend that could hugely benefit both employers and staff over the next ten years, creating a skills-based economy in which all members can thrive to counter the Great Resignation.

You may also be interested in...



Fighting For Diverse Talent in Biopharma

In the United States, where Black inequity has become a focus of diversity efforts, biopharma companies are working hard to recruit and retain individuals from these communities. In fact, the search for such employees and leaders has become so competitive that competition for diverse talent within the industry is now "fierce," as one executive told In Vivo.   

The Evolving World Of Work: Recruitment Trends And The Changing Face Of The C-Suite

A veteran talent recruiter talks about the recent hiring trends in pharma, the mistakes that companies make when hiring candidates and how to navigate the ‘ego factor’.

The Mandate To Make A Digital Difference

Diogo Rau, chief information and digital officer at Lilly, talks to In Vivo about the company’s plans for making big and disruptive changes using digital strategy to speed up drug development.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

IV146691

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel